Gardner’s syndrome (GS), a variant of familial adenomatous polyposis, is an autosomal dominant disease. Originally, Gardner described a syndrome consisting of hereditary intestinal polyposis with osteomas and multiple cutaneous and subcutaneous lesions [1] (Figs. 1 and 2). The syndrome was later modified by the addition of other features, such as dental abnormalities, abdominal fibromatosis, and a number of malignant tumors. The principal cutaneous lesions that have been described in GS are epidermoid cysts. Other cutaneous lesions include fibromas, lipomas, leiomyomas, neurofibromas, and pigmented skin lesions [2]. Fibromatoses are histologically benign, but locally aggressive fibrous tumors consisting of mature fibroblasts within an extensive collagen matrix. Most cases are sporadic, but there is a clear association with familial adenomatous polyposis and GS, suggesting a link with a mutation of the APC gene on chromosome 5q22 [3]. Fibromatosis occurs in 3.5%–29% of patients with GS, and is more likely to be multiple and to involve the mesentery and abdominal wall rather than being an isolated form [4, 5]. Clinically, fibromatosis presents as a painless firm soft tissue mass. Most cases of fibromatosis are believed to be precipitated by surgical trauma; however, a few cases of spontaneous occurrence have been reported [6]. In our patient, no history of abdominal surgery or trauma was present. In addition, an abdominal CT obtained 2 years ago revealed no abnormality.
Although the radiological features of fibromatosis on CT or MR have been described in the literature, F-18 FDG-PET or PET/CT findings are rarely reported [7–10]. The F-18 FDG uptake in patients with fibromatosis ranged from low to moderate grade and was generally heterogenous with a few tiny foci of relatively intense uptake or relatively homogenous. The areas of higher FDG metabolism are likely to represent more cellular and mitotically active areas [7]. Mesenteric fibromatosis has similar findings to extra-abdominal lesions [7, 9] (Fig. 3).
Acknowledgments
Conflict of Interest
The authors declare that they have no conflict of interest.
References
- 1.Gardner EJ, Richards RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet. 1953;5:139–47. [PMC free article] [PubMed] [Google Scholar]
- 2.Ascari-Raccagni A, Baldari U, Righini MG. Cutaneous symptoms of Gardner's syndrome. J Eur Acad Dermatol Venereol. 1999;12:80–1. doi: 10.1111/j.1468-3083.1999.tb00824.x. [DOI] [PubMed] [Google Scholar]
- 3.Clark SK, Phillips RK. Desmoids in familial adenomatous polyposis. Br J Surg. 1996;83:1494–504. doi: 10.1002/bjs.1800831105. [DOI] [PubMed] [Google Scholar]
- 4.Naylor EW, Gardner EJ, Richards RC. Desmoid tumors and mesenteric fibromatosis in Gardner's syndrome: Report of Kindred 109. Arch Surg. 1979;114:1181–5. doi: 10.1001/archsurg.1979.01370340087015. [DOI] [PubMed] [Google Scholar]
- 5.Kawashima A, Goldman SM, Fishman EK, Kuhlman JE, Onitsuka H, Fukuya T, et al. CT of intraabdominal desmoid tumors: Is the tumor different in patients with Gardner's disease? AJR Am J Roentgenol. 1994;162:339–42. doi: 10.2214/ajr.162.2.8310922. [DOI] [PubMed] [Google Scholar]
- 6.Richards RC, Rogers SW, Gardner EJ. Spontaneous mesenteric fibromatosis in Gardner's syndrome. Cancer. 1981;47:597–601. doi: 10.1002/1097-0142(19810201)47:3<597::AID-CNCR2820470329>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
- 7.Basu S, Nair N, Banavali S. Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: Potential clinical role of FDG-PET in the management. Br J Radiol. 2007;80:750–6. doi: 10.1259/bjr/53719785. [DOI] [PubMed] [Google Scholar]
- 8.Maeda R, Isowa N, Onuma H, Miura H, Tokuyasu H, Kawasaki Y. Desmoid tumor of the chest wall in an elderly woman. Gen Thorac Cardiovasc Surg. 2009;57:554–7. doi: 10.1007/s11748-008-0404-y. [DOI] [PubMed] [Google Scholar]
- 9.Lo KW. Mesenteric fibromatosis as a potential source of false-positive interpretation of FDG-PET: Report of a case. Dis Colon Rectum. 2007;50:924–6. doi: 10.1007/s10350-006-0826-5. [DOI] [PubMed] [Google Scholar]
- 10.Kasper B, Dimitrakopoulou-Strauss A, Strauss LG, Hohenberger P. Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib. Eur J Nucl Med Mol Imaging. 2010;37:1876–82. doi: 10.1007/s00259-010-1498-x. [DOI] [PubMed] [Google Scholar]